Vir Biotechnology Inc.

09/09/2024 | Press release | Distributed by Public on 09/09/2024 14:06

Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best in Class Clinical Stage T Cell Engagers